If there are two different sources combined, the Infusion could be between $12m and $13.5m. Interestlingly this is in the same range like the $12.5m revolving credit with Platinum some years ago. I guess this should be enough to move things forward.
(1)
(0)
Decision Diagnostics Corp (DECN) Stock Research Links